ライフサイエンスコーパス: low income

1 identified racial minorities and people with low income.

2 ce of depression only among individuals with low income.

3 Two of 15 (13%) low-income, 4 of 16 (25%) lower-middle-income, 14 of 20

4 Fifty-four percent of participants had a low income, 40% had a low educational level, and 17% had

5 es in the follow-up study (421 [69.6%]) were low income; 680 (85.9%) identified as non-Latino black,

6 me: adjusted HR, 0.96; 95% CI, 0.82 to 1.12; low income: adjusted HR, 1.06; CI, .88 to 1.27).

7 A total of 1432 low-income adult patients with uncontrolled hypertension

8 e and post-HF survival by race and sex among low-income adults in the southeastern United States.

9 coverage, health care use, and health among low-income adults.

10 xpanded Medicaid eligibility for millions of low-income adults.

11 In May, 2012, Rwanda became the first low-income African country to introduce pentavalent rota

12 ecades of income growth and longevity gains, low-income Americans are increasingly left behind.

13 ess to salutary determinants of health among low-income Americans.

14 Older age, rural residence, low income and more advanced disease were significantly

15 s an increasingly strong association between low income and poor health.

16 usters of CAP cases were found in areas with low-income and black/African American populations.

17 nding targets and that spending gaps between low-income and high-income countries are unlikely to nar

18 d disproportionately afflict those living in low-income and lower-middle-income countries (LLMICs).

19 g trends and relationships suggest that many low-income and lower-middle-income countries will not me

20 at US$7.5 billion worldwide ($3.4 billion in low-income and lower-middle-income countries), but decre

21 95 (37%) had no national policy (25/33 from low-income and lower-middle-income countries).

22 and access to antimicrobials, especially in low-income and lower-middle-income countries, but increa

23 boosted protease inhibitor-based regimens in low-income and middle income countries.

24 n 179 Demographic and Health Surveys from 64 low-income and middle-income countries (1993-2015).

25 f blood pressure-lowering drugs was lower in low-income and middle-income countries (except for India

26 ave much lower pollutant concentrations than low-income and middle-income countries (LMICs) and diffe

27 ch on the correlates of physical activity in low-income and middle-income countries (LMICs) is provid

28 income countries (HICs) and at least 20% for low-income and middle-income countries (LMICs) on the ba

29 mmonest cancers diagnosed in women living in low-income and middle-income countries (LMICs), where op

30 of the global burden of injuries is borne by low-income and middle-income countries (LMICs).

31 done of the interventions adapted for use in low-income and middle-income countries (LMICs).

32 ors (NNRTIs) might compromise HIV control in low-income and middle-income countries (LMICs).

33 tobacco use among people living with HIV in low-income and middle-income countries (LMICs).

34 planning exercises might be useful for other low-income and middle-income countries aiming to improve

35 ng to maternal mortality from anaesthesia in low-income and middle-income countries and the burden of

36 llion children (43%) younger than 5 years in low-income and middle-income countries are at risk of no

37 children exposed to the two risk factors in low-income and middle-income countries decreased from 27

38 ge we describe could be a starting place for low-income and middle-income countries developing univer

39 TATION: A large proportion of communities in low-income and middle-income countries do not have acces

40 ealth issues, few population-based data from low-income and middle-income countries exist about the l

41 hese inequities highlight the urgent need in low-income and middle-income countries for sustainable i

42 We developed projections for 67 low-income and middle-income countries from 2016 to 2030

43 nt of SDG 3 and universal health coverage in low-income and middle-income countries have been publish

44 stunted or lived in extreme poverty for 141 low-income and middle-income countries in 2004 and 2010.

45 with the new countries largely consisting of low-income and middle-income countries in Africa.

46 People with HIV-1 in low-income and middle-income countries increasingly need

47 health and government spending on health in low-income and middle-income countries is allocated to t

48 s with large sample sizes; (5) research from low-income and middle-income countries is conspicuous by

49 line in mean height-for-age Z score (HAZ) in low-income and middle-income countries is driven by rela

50 ivate sector to improve population health in low-income and middle-income countries is heavily debate

51 e association between suicide and poverty in low-income and middle-income countries is scarce.

52 Private health care in low-income and middle-income countries is very extensive

53 settings (global network) and for studies in low-income and middle-income countries only (LMIC networ

54 HIV testing in paediatric populations in low-income and middle-income countries outside the conte

55 near growth faltering (known as stunting) in low-income and middle-income countries remain inadequate

56 its enormous burden, maternal depression in low-income and middle-income countries remains under-rec

57 itigate postnatal linear growth faltering in low-income and middle-income countries should prioritise

58 Low-income and middle-income countries that introduce PC

59 tions and behaviours and economic poverty in low-income and middle-income countries using bivariate o

60 Such assessments are especially important in low-income and middle-income countries, and in the anima

61 ognosis, surveillance, and vector control in low-income and middle-income countries, as well as poten

62 INTERPRETATION: In low-income and middle-income countries, declines in mean

63 ough robust prevalence studies are sparse in low-income and middle-income countries, elder abuse seem

64 s worldwide and in high-income countries and low-income and middle-income countries, from 1990 to 201

65 In low-income and middle-income countries, invasive mechani

66 is an important health-care provider in many low-income and middle-income countries, its role in prog

67 Although limited data were available for low-income and middle-income countries, our findings sug

68 nmental, and metabolic risk clusters, in the low-income and middle-income countries, the PAF of behav

69 m 17 randomised controlled trials done in 14 low-income and middle-income countries, which compared m

70 sease rates, and increasing air pollution in low-income and middle-income countries.

71 ead use of pneumococcal conjugate vaccine in low-income and middle-income countries.

72 lth, social, and economic burden on numerous low-income and middle-income countries.

73 cause of diarrhoeal death among children in low-income and middle-income countries.

74 and children are increasing steadily in most low-income and middle-income countries.

75 e initiating antiretroviral therapy (ART) in low-income and middle-income countries.

76 STIs disproportionately affect low-income and middle-income countries.

77 -income countries compared with reports from low-income and middle-income countries.

78 orbidities were missing for some children in low-income and middle-income countries.

79 l registration and vital statistics in other low-income and middle-income countries.

80 representing 95% of the total population in low-income and middle-income countries.

81 cause of death and disability, especially in low-income and middle-income countries.

82 post-partum periods) among women residing in low-income and middle-income countries.

83 patients with acute respiratory infection in low-income and middle-income countries.

84 large and growing role in health systems in low-income and middle-income countries.

85 forts to secure universal health coverage in low-income and middle-income countries.

86 ng services to manage maternal depression in low-income and middle-income countries.

87 y outcomes, particularly in rapidly changing low-income and middle-income countries.

88 en maternal depression and child outcomes in low-income and middle-income countries.

89 ing 3% of total public spending on health in low-income and middle-income countries.

90 itions are having in China, India, and other low-income and middle-income countries.

91 yet universal access is often undermined in low-income and middle-income countries.

92 wide, with over 75% of suicides occurring in low-income and middle-income countries.

93 oviding access to timely and safe surgery in low-income and middle-income countries.

94 he health of women globally, particularly in low-income and middle-income countries.

95 tions and behaviours and economic poverty in low-income and middle-income countries.

96 sation centres) in paediatric populations in low-income and middle-income countries.

97 ions of such private sector interventions in low-income and middle-income countries.

98 rient deficiencies are common among women in low-income and middle-income countries.

99 achievement of the SDGs for China and other low-income and middle-income countries.

100 t at large scale to HIV-positive patients in low-income and middle-income countries.

101 atment and prevention of mental disorders in low-income and middle-income countries.

102 were from published multinational cohorts in low-income and middle-income countries.

103 have become major features of cities in many low-income and middle-income countries.

104 e countries, but few data are available from low-income and middle-income countries.

105 ease-causing serotypes that are important in low-income and middle-income countries.

106 rth, birth outcomes, and infant mortality in low-income and middle-income countries.

107 ory to comorbidities and multimorbidities in low-income and middle-income countries.

108 is essential for control of hypertension in low-income and middle-income countries.

109 ial impact on RSV-related child mortality in low-income and middle-income countries.

110 scular death and disability, particularly in low-income and middle-income countries.

111 cing sources to sustain health programmes in low-income and middle-income countries.

112 98% of all stillbirths occur in low-income and middle-income countries; 77% in south Asi

113 and systems of care to address syndemics in low-income and middle-income country settings.

114 ions among children aged 1-4 years living in low-income and middle-income settings constitute most of

115 Low-income and minority mothers experience a disproporti

116 f data on heart failure (HF) incidence among low-income and minority populations.

117 palliative care--are increasingly needed in low-income and particularly in middle-income countries,

118 atial concept of slums to argue that, in all low-income and-middle-income countries, census tracts sh

119 reas linked with overcrowding, homelessness, low income, and recent immigration to the UK, which was

120 documented in countries of high, middle, and low-income, and across different types of health-care sy

121 ess, area income and individual income, both low-income area and low individual household income, wer

122 or HF at a university hospital centered in a low-income area of Columbus, Ohio.

123 erall (OR = 0.55, 95% CI: 0.34, 0.89) and in low-income areas (OR = 0.54, 95% CI: 0.33, 0.88).

124 ce interval (CI): 0.55, 0.88), especially in low-income areas (OR = 0.69, 95% CI: 0.54, 0.87).

125 Food deserts (FD), neighborhoods defined as low-income areas with low access to healthy food, are a

126 low-up of 692 middle-aged (46.7+/-12.3 yrs), low-income BACH/Bone cohort participants.

127 allergic asthma (aged 6-17 yr; n = 478) from low-income census tracts in eight U.S. cities, and we an

128 This risk was particularly high among low-income communities (RR 1.076; 95% CI, 1.052, 1.100).

129 ty mental health treatment infrastructure in low-income communities.

130 od pressure than was consistent residence in low-income communities.

131 ne fractures and osteoporosis, especially in low-income communities.

132 f live oral rotavirus vaccines is reduced in low-income compared with high-income settings.

133 The adaptive policy optimized for low-income contexts achieved 6.142 average QALYs at a co

134 levels, although hospitalization rates among low-income counties lag behind those of the higher incom

135 milar for all county income groups; however, low-income counties lagged behind high-income counties b

136 , 31.4%, and 31.1%, for high-, average-, and low-income counties, respectively) to 2013 (26.2%, 26.1%

137 would be required to make an intervention in low income countries that can eradicate or control human

138 rld Bank's cost-effectiveness thresholds for low income countries).

139 turing capability available in both high and low income countries.

140 blood pressure-lowering medicines was 31% in low-income countries (1069 of 3479 households), 9% in mi

141 mports, particularly of plants and pets) and low-income countries (air travel).

142 Although S. flexneri causes most disease in low-income countries (following ingestion of contaminate

143 cute kidney injury are scarce, especially in low-income countries (LICs) and lower-middle-income coun

144 this unmet need resides disproportionally in low-income countries (LICs).

145 le-income countries (107 of 227), and 13% in low-income countries (nine of 68).

146 epends on the poverty line but might in some low-income countries account for as much as four percent

147 s suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income co

148 of (current) gross national income (GNI) in low-income countries and 5.2% of GNI in lower-middle-inc

149 sed by Treponema pallidum that is endemic in low-income countries and and occurs at lower rates in mi

150 Health apps in low-income countries are emerging tools with the potenti

151 obability of being highly cost effective for low-income countries at neonatal mortality rates of 30 o

152 l conjugate vaccines (PCVs) are used in many low-income countries but their impact on the incidence o

153 however, its availability is very limited in low-income countries due to cost and operational constra

154 high-income countries and middle-income and low-income countries for clinical trials training and re

155 Rwanda was one of the first low-income countries in sub-Saharan Africa to introduce

156 Most importantly, health spending in many low-income countries is expected to remain low.

157 men (using a >/=10% risk threshold), and in low-income countries ranged from 2% in Uganda (men and w

158 ntiretroviral therapy (ART), availability in low-income countries remains limited.

159 In 1995 and 2015, low-income countries spent $0.03 for every dollar spent

160 untries and with returns generally higher in low-income countries than in countries of lower-middle a

161 vaccine is less immunogenic and effective in low-income countries than in high-income countries, simi

162 ation programs of 79 countries, including 36 low-income countries that are eligible for support for v

163 Low-income countries that introduce PCV13 with reasonabl

164 increasing initiatives in basic resources in low-income countries to rapid learning systems in high-i

165 r implementation of rotavirus vaccination in low-income countries where >90% global deaths from rotav

166 olerance, limiting its usefulness in hot and low-income countries where malaria prevails.

167 ions of individuals worldwide, especially in low-income countries where their management is suboptimu

168 al contexts in which IWS systems often exist-low-income countries with under-resourced utilities and

169 In low-income countries, childhood wasting was the leading

170 ted lower vaccine efficacy among children in low-income countries, compared with their counterparts i

171 rticularly in Thailand and most neighbouring low-income countries, screening colonoscopy is not yet r

172 h, and quality of evidence particularly from low-income countries, to strengthen the uptake and inter

173 The results are highly relevant in low-income countries, where quality of care is challenge

174 However, most low-income countries, where the burden of disease is gre

175 cause of illness and death among children in low-income countries.

176 th the majority now occurring in middle- and low-income countries.

177 .7 (95% CI 5.3-6.1), with the effect high in low-income countries.

178 sional's management of childhood diarrhea in low-income countries.

179 target individuals for medical treatment in low-income countries.

180 me and upper-middle-income countries than in low-income countries.

181 pper-middle-income, lower-middle-income, and low-income countries.

182 nd middle-income countries, and also in many low-income countries.

183 mortality in high-income, middle-income, and low-income countries.

184 a major cause of morbidity and mortality in low-income countries.

185 RVGE), mirroring vaccine underperformance in low-income countries.

186 ding cause of blindness in middle-income and low-income countries.

187 pper middle-income, lower middle-income, and low-income countries.

188 sional's management of childhood diarrhea in low-income countries.

189 ities caring for women and newborn babies in low-income countries.

190 childhood cancers, including adaptations for low-income countries.

191 posed and may improve vaccine performance in low-income countries.

192 upper-middle-income than in lower-middle- or low-income countries.

193 sionals' management of childhood diarrhea in low-income countries.

194 oxy measure for the impact of the vaccine in low-income countries.

195 Results were similar for middle-income and low-income countries.

196 rs; however, limited data are available from low-income countries.

197 f services and is increasingly recognised in low-income countries.

198 f cancer treatment, its access is limited in low-income countries.

199 Climate and health co-benefits in low-income countries: a case study of carbon financed wa

200 g cause of premature death and disability in low-income countries; however, few receive optimal benza

201 n additional US$21 per person in the average low-income country and $24 in the average lower-middle-i

202 emiology of ARDS has not been reported for a low-income country at the level of the population, hospi

203 llection even among severely ill children in low-income-country settings.

204 applied to a different environment (e.g., a low-income environment with fewer career opportunities).

205 lescents, young adults, and individuals from low-income families (who consume more sugar-sweetened be

206 Adults from low-income families manifest more allostatic load, an in

207 L) among asthmatic children, especially from low-income families, has not been fully investigated.

208 Focusing on children from low-income families, we find that growing up in a county

209 In female adolescents, the high-inequality low-income group displayed the greatest age-related decr

210 argument for widespread utilization in other low-income, high-burden settings.

211 [aOR], 1.12; 95% CI, 1.01-1.24; P = .04) or low-income households (aOR, 1.12; 95% CI, 1.00-1.25; P =

212 Low-income households may be disproportionately affected

213 living in high-inequality neighborhoods and low-income households may experience greater HPA and HPG

214 Non-Hispanic black households and low-income households obtain both higher absolute and re

215 rchased in 2009-2012 were slower for NHB and low-income households than for NHW and high-income house

216 Ozone reductions are highest among low-income households, which increases their relative we

217 valuate the benefits of ozone reductions for low-income households.

218 nsumption of SSBs, with larger decreases for low-income households.

219 = 44) and floor sponge samples (n = 44) from low-income-households in Dhaka were assayed for fecal in

220 that higher levels of community trust among low-income individuals lead to less myopic decisions.

221 Low-income individuals may be both less likely to believ

222 Specifically, we hypothesize that low-income individuals with higher community trust make

223 We investigated whether 3 SES correlates-low income, low education, and high perceived stress-wer

224 For at-risk (single parent, low income, low support) mothers, healthy adaptation and

225 We examined investments in countries of low income, lower-middle income, and upper-middle income

226 We did a systematic review of studies from low-income, middle-income, and high-income countries by

227 ovascular disease from 613 communities in 18 low-income, middle-income, and high-income countries in

228 mortality and CVD events in individuals from low-income, middle-income, and high-income countries.

229 Importance: Low-income minority children living in urban neighborhoo

230 prevent problems and reduce disparities for low-income minority children.

231 cally affiliated community clinics serving a low-income minority population.

232 nting a research intervention in a cohort of low-income, minority patients.

233 shown that residents of African American and low-income neighborhoods have less access to grocery sto

234 f income-can partially offset the effects of low income on myopic decisions.

235 conomic data for 113 countries classified as low income or lower-middle income by the World Bank in 2

236 e present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) fr

237 ated deaths was 5.0 months (IQR 2.3-11.0) in low-income or lower middle-income countries, 4.0 years (

238 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) we

239 tetric procedure in countries categorised as low-income or middle-income by the World Bank.

240 d 27 studies undertaken in 16 countries-five low-income or middle-income countries (Bangladesh, Colom

241 e countries with limited translation, and in low-income or middle-income countries.

242 lts who were uninsured, were unemployed, had low income, or had behavioral health problems.

243 depression among middle-income compared with low-income participants (adjusted odds ratio [aOR] 0.98,

244 Higher cost sharing for seriously ill and low-income patients could discourage treatment of vulner

245 Among this cohort of racially diverse low-income patients hospitalized with HF, an appointment

246 Low-income patients in Argentina with uncontrolled hyper

247 However, the decrease was largest in low-income patients who resided in expansion states (9.6

248 ld improve blood pressure (BP) control among low-income patients with hypertension.

249 , hospitals that treat a large proportion of low-income patients) and other hospitals.

250 ecially at centers caring for vulnerable and low-income patients.

251 ubstantially after the ACA, especially among low-income people who resided in Medicaid expansion stat

252 We conclude that reducing housing support to low-income persons in the private rental sector increase

253 pril 2011 reduction in financial support for low-income persons who rent private-sector housing (mean

254 d risk factors for mortality due to RSV in a low-income population of 84,840 infants.

255 ce to recommended survivorship care, among a low-income population of breast cancer survivors (surviv

256 In this low-income population, HF incidence was higher for all r

257 mental health treatment resources that serve low-income populations across local communities.

258 nths of which offer payment arrangements for low-income populations), (2) office-based practice of me

259 was the most frequent cause of mortality in low-income postneonatal infants.

260 men, Infants, and Children (WIC program) for low-income postpartum women could produce greater weight

261 Among low-income postpartum women, an internet-based weight lo

262 Methods We recruited 212 low-income, predominantly Latina (72.6%) survivors with

263 ase or nonsustained ventricular tachycardia, low-income prescription benefits subsidy, and less recen

264 sy or intervention, comorbidity, black race, low income, public insurance, and NS-colo were associate

265 s for rabies prophylaxis after exposure in a low-income rabies-endemic setting.

266 320 predominantly low-income, racially diverse adults with nonspecific cLB

267 nd clinical risk factors to RSV mortality in low-income regions is unclear.

268 In some low-income regions, a combination of ecological, agricul

269 commended but not widely implemented in some low-income regions.

270 to identify the need for further research in low-income regions.

271 In conclusion, the prevalence of MetS in low income rural adults of Xinjiang was high and the LAP

272 Across high-income and low-income settings alike, there often remains a dearth

273 health systems that is transferable to other low-income settings and that garners political will, bui

274 Low-income settings challenge the level of protection pr

275 tine resistance testing in ART programmes in low-income settings for the purpose of selecting second-

276 dicted to be effective and cost-effective in low-income settings in sub-Saharan Africa at any prevale

277 ens is a public health concern especially in low-income settings where these sources are used untreat

278 ale up water treatment and improve health in low-income settings, these results suggest program effec

279 In low-income settings, vaccination campaigns supplement ro

280 ators across high-income, middle-income, and low-income settings.

281 S was a disease that could not be managed in low-income settings.

282 aving, but can be prohibitively expensive in low-income settings.

283 er efficacy of RV vaccines in this and other low-income settings.

284 istration expertise beyond that available in low-income settings.

285 of routine vaccination against rotavirus in low-income settings.

286 f invasive disease in infants, especially in low-income settings.

287 l 2016 among 2 cohorts of young infants in 4 low-income settlements in Karachi, Pakistan.

288 In low-income smokers who did not receive face-to-face or t

289 mproved long-term smoking cessation rates in low-income smokers, in a general population setting, wit

290 6; 95% CI, 1.05-2.94; P = .03), those with a low-income status (RR, 2.09; 95% CI, 1.20-3.65; P = .01)

291 ut-of-pocket costs for beneficiaries without low-income subsidies who take a single drug before and a

292 Purpose The low-income subsidy (LIS) substantially lowers out-of-poc

293 for severe and mild disorders and larger in low-income than in high-income neighborhoods.

294 Children with asthma in low-income urban areas have high morbidity.

295 hma morbidity, but not for prevalence, among low-income US children.

296 was a randomized experiment that moved very low-income US families from high-poverty neighborhoods t

297 We studied the health of low-income US women affected by the largest social polic

298 tected for the current rotavirus vaccines in low-income versus high-income settings.

299 directed at providing affordable coverage to low-income, vulnerable populations.

300 ctive interventions exist for multicultural, low-income women.